Related Experiment Video
Updated: Sep 22, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
5‑Aza‑dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
Yang-Jie Zhang1, Ran Xie2, Jie Jiang2
1Department of Orthopedics (Spine Special), Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Cancer Center of Yunnan Province, Kunming, Yunnan 650118, P.R. China.
Abstract:
The in‑depth study of melanoma pathogenesis has revealed that epigenetic modifications, particularly DNA methylation, is a universal inherent feature of the development and progression of melanoma. In the present study, the analysis of the tumor suppressor gene growth arrest‑specific transcript 5 (GAS5) demonstrated that its expression was downregulated in melanoma, and its expression level had a certain negative association with its methylation modification level. The promoter of GAS5 presented with detectable CpG islands, and methylation‑specific polymerase chain reaction analysis demonstrated that GAS5 was actually modified by methylation in melanoma tissues and cells; however, no methylation modification of GAS5 was detected in normal tissues. Following the treatment of melanoma cells with 5‑Aza‑2'‑deoxycytidine (5‑Aza‑dC), GAS5 methylation was significantly reversed. The analysis of melanoma cell proliferation revealed that 5‑Aza‑dC inhibited A375 and SK‑MEL‑110 cell proliferation in a time‑dependent manner. Further analysis of apoptosis demonstrated that 5‑Aza‑dC significantly increased the apoptosis level of the two cell lines. Moreover, migration analysis of melanoma cells revealed that 5‑Aza‑dC significantly reduced cell migration. Furthermore, 5‑Aza‑dC significantly decreased the invasive ability of the two cell lines. However, when the expression of GAS5 was silenced, the effects of 5‑Aza‑dC on cell proliferation, apoptosis, invasion and migration were not significant. Furthermore, the subcutaneous injection of A375 cells in nude mice successfully resulted in xenograft tumor formation. However, following an intraperitoneal injection of 5‑Aza‑dC, the volume and weight of xenograft tumors and Ki‑67 expression were significantly reduced, and caspase‑3 activity and GAS5 expression were enhanced; following the silencing of GAS5, the antitumor effect of 5‑Aza‑dC was significantly blocked. On the whole, the present study demonstrates that 5‑Aza‑dC inhibits the growth of melanoma, and its function may be related to the methylation modification of GAS5.
Insights
Epigenetic modifications, specifically DNA methylation of the GAS5 gene, are key in melanoma development. Treatment with 5-Aza-2'-deoxycytidine (5-Aza-dC) reverses GAS5 methylation, inhibiting melanoma growth and progression.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic modifications, particularly DNA methylation, are fundamental to melanoma pathogenesis.
- The tumor suppressor gene growth arrest-specific transcript 5 (GAS5) is downregulated in melanoma.
- GAS5 expression negatively correlates with its methylation levels in melanoma.
Purpose of the Study:
- To investigate the role of GAS5 methylation in melanoma development and progression.
- To evaluate the therapeutic potential of 5-Aza-2'-deoxycytidine (5-Aza-dC) in melanoma.
- To elucidate the mechanism by which 5-Aza-dC exerts its anti-melanoma effects.
Main Methods:
- Analysis of GAS5 expression and methylation in melanoma tissues and cells.
- Treatment of melanoma cells with 5-Aza-dC and assessment of proliferation, apoptosis, migration, and invasion.
- In vivo studies using xenograft models in nude mice to evaluate the anti-tumor efficacy of 5-Aza-dC.
Main Results:
- GAS5 promoter is methylated in melanoma tissues/cells but not in normal tissues.
- 5-Aza-dC treatment reversed GAS5 methylation, inhibited cell proliferation, increased apoptosis, and reduced migration and invasion.
- In vivo, 5-Aza-dC significantly reduced tumor volume, weight, and Ki-67 expression, while enhancing caspase-3 activity and GAS5 expression.
Conclusions:
- 5-Aza-dC demonstrates significant anti-melanoma effects, potentially mediated through the reversal of GAS5 methylation.
- GAS5 methylation plays a crucial role in melanoma progression, and its modulation represents a potential therapeutic strategy.
- The study highlights the therapeutic potential of targeting epigenetic modifications in melanoma treatment.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Induced Pluripotent Stem Cells
Somatic...

